Sierra Oncology Inc (SRRA) Stock Balance Sheet
NASDAQ:SRRA - Nasdaq - US82640U4040 - Common Stock
| MRQ (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.45M | 2.22M | 2.10M | 1.30M | 800.00K | |||
| Cash Equivalents | 271.56M | 102.53M | 101.90M | 146.20M | 105.20M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 270.00K | 150.00K | 300.00K | 200.00K | 900.00K | |||
| Other Current Assets | 3.91M | 2.49M | 2.10M | 2.20M | 1.80M | |||
| Total Current Assets | 278.20M | 107.39M | 106.50M | 149.90M | 108.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 840.00K | 930.00K | 400.00K | 700.00K | 200.00K | |||
| Other Non-Current Assets | 970.00K | 1.04M | 600.00K | 700.00K | 500.00K | |||
| Total Non-Current Assets | 1.80M | 1.98M | 1.00M | 1.40M | 700.00K | |||
| TOTAL ASSETS | 280.00M | 109.37M | 107.50M | 151.30M | 109.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 11.28M | 10.73M | 7.10M | 7.20M | 8.80M | |||
| Accounts Payable | 1.80M | 2.16M | 2.20M | 1.00M | 1.30M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 56.40M | N/A | |||
| Total Current Liabilities | 13.08M | 12.88M | 9.40M | 64.60M | 10.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 4.86M | 0.00 | 0.00 | 0.00 | 4.90M | |||
| Other Non-Current Liabilities | 440.00K | 480.00K | 200.00K | 400.00K | N/A | |||
| Total Non-Current Liabilities | 5.30M | 490.00K | 100.00K | 400.00K | 4.90M | |||
| TOTAL LIABILITIES | 18.38M | 13.37M | 9.50M | 65.00M | 15.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -969.18M | -941.25M | -846.60M | -765.70M | -677.40M | |||
| Additional Paid In Capital | 1.23B | 1.04B | 944.50M | 852.00M | 771.80M | |||
| Common Shares | 20.00K | 20.00K | 0.00 | 100.00K | 100.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 23.80M | 15.57M | 11.10M | 1.90M | 1.90M | |||
| Tangible Book Value per Share | N/A | 6.16 | 8.83 | 45.42 | 49.74 | |||
| Total Shareholders' Equity | 261.62M | 96.00M | 98.00M | 86.30M | 94.50M | |||
| TOTAL LIABILITIES AND EQUITY | 280.00M | 109.37M | 107.50M | 151.30M | 109.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | N/A | N/A | N/A | 0.05 | |||
| Current Ratio | 21.27 | 8.34 | 11.33 | 2.32 | 10.77 | |||
| Return On Assets (ROA) | -36.67% | -86.55% | -75.26% | -58.35% | -48.71% | |||
| Return On Equity (ROE) | -39.25% | -98.60% | -82.55% | -102.29% | -56.44% | |||
All data in USD , ROIC based on taxRate of 0.21